tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Liav Abraham, 18 are a HOLD (22.5%), 60 are a BUY (75%), 2 are a SELL (2.5%).
Analyst Liav Abraham, currently employed at CITI, carries an average stock price target met ratio of 62.01% that have a potential upside of 15.5% achieved within 419 days.
Liav Abraham’s has documented 159 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TEVA, Teva Pharma Industries Ltd ADR at 30-Apr-2021.
Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for TEVA (TEVA PHARMA INDUSTRIES LTD ADR) at 5/1/2018. The price target of $24 was fulfilled within 42 days with a profit of $5.29 (28.27%) receiving and performance score of 6.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Dec-2016
$193
$-0.02 (-0.01%)
6 years 6 months 4 days ago
(21-Apr-2020)
2/8 (25%)
$8.96 (4.87%)
125
Hold Since 08-May-2019
$203
$9.98 (5.17%)
$178
6 years 8 months 15 days ago
(10-Feb-2020)
5/19 (26.32%)
$4.87 (2.46%)
74
Buy Since 03-Aug-2017
$198
$4.98 (2.58%)
$188
6 years 9 months 3 days ago
(22-Jan-2020)
3/12 (25%)
$7.8 (4.10%)
176
Buy Since 03-Aug-2015
$200
6 years 11 months 6 days ago
(19-Nov-2019)
2/12 (16.67%)
$73.92 (58.63%)
290
Hold Since 19-Nov-2019
$203
$9.98 (5.17%)
$189
6 years 11 months 6 days ago
(19-Nov-2019)
1/2 (50%)
$19.19 (10.44%)
96
What Year was the first public recommendation made by Liav Abraham?
